RecruitingNot Applicable

SNAG and SNME in Non-Specific Sciatic Pain

Turkey (Türkiye)30 participantsStarted 2025-07-01

Plain-language summary

This study is designed as a crossover trial. All participants who meet the inclusion criteria and voluntarily agree to participate will be evaluated using the assessment methods detailed below. Subsequently, participants will be randomly assigned into two groups. The first group (Mulligan Concept Group - MCG) will receive the SNAG technique, while the second group (Neural Mobilization Group - NMG) will perform the Sciatic Nerve Mobilization Exercise (SNME). After the intervention, participants will be evaluated a second time. Ten days after this session, participants will be invited back. Those who were in the MCG group during the first session will be re-evaluated and then receive the SNGE intervention. Participants who were in the SNGE group during the first session will be re-evaluated and then receive the SNAG intervention. Following this second intervention, participants will be evaluated once again. Assessments will be done are Demographic Form, Visual Analogue Scale, Oswestry Disability Index, Joint Range of Motion, Five-times Sit-to-stand Test, Sit and Reach Test

Who can participate

Age range

20 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults between the ages of 20 and 50, * Individuals describing non-specific sciatic pain characterized by unilateral low back pain accompanied by radiating symptoms to the leg, * Duration of pain longer than 12 weeks, * Presence of pain during the Slump Test and Straight Leg Raise Test, * No history of any physical therapy or intervention in the past month. b: Exclusion Criteria: * Individuals diagnosed with herniated disc or spinal stenosis by a physician, * Physician-diagnosed secondary neurological conditions, * History of spinal surgery, * Individuals describing the origin of their pain as the lower back (without leg involvement), * Presence of neurological symptoms (e.g., foot drop, significant muscle weakness), * Serious medical conditions that may affect treatment or outcomes (e.g., cancer, infections, or inflammatory diseases), * Pregnancy or recent childbirth (within the past year), * Use of medications that may affect pain perception or mobility (e.g., opioids), * Inability to comply with the weekly treatment schedule.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Oswestry Disability Index (ODI)

Timeframe: Through study completion, an average of 1 year

5 Times Sit to Stand Test

Timeframe: Through study completion, an average of 1 year

Sit and Reach Test

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT07161323

SponsorIstinye University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01

Contact for this trial

Sohiab Hassan Mohamed Wagdy Ahmed Elsayed Eladawi, Physiotherapist

+905415142895 sohiabhasan@gmail.com

View on ClinicalTrials.gov More Sciatica Pain trials

Plain-language summary

Who can participate

Age range

20 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.